Clinical Trials Logo

Infectious Keratitis clinical trials

View clinical trials related to Infectious Keratitis.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04383431 Completed - Clinical trials for Infectious Keratitis

Cross-linking as Treatment in Infectious Keratitis

Start date: June 2, 2020
Phase: N/A
Study type: Interventional

To compare between SCXL and ACXL for treatment of infectious keratitis

NCT ID: NCT04213313 Completed - Clinical trials for Infectious Keratitis

Association Between SNP of SP-D and Susceptibility and Prognosis of Infectious Keratitis

ABSOSASAPOIK
Start date: October 1, 2016
Phase:
Study type: Observational [Patient Registry]

This study explores the association between single nucleotide polymorphism (Met11Thr) of surfactant protein D(SP-D) and susceptibility and prognosis of infectious keratitis.Met11Thr of SP-D of patients with keratitis and normal controls were compared.Allele and genotype frequencies of patients with keratitis and normal controls were determined by polymerase chain reaction with sequence specific primers(PCR-SSPs) .SP-D gene polymorphism of patients with keratitis and normal controls was detected by Sanger sequencing

NCT ID: NCT04030403 Completed - Clinical trials for Infectious Keratitis

Investigation of the Microbiome of the Cornea in Microbial Keratitis

STOICA
Start date: September 10, 2019
Phase:
Study type: Observational

Design: Prospective observational diagnostic study and methods-comparison. Aims: The overall aim of the project is to better define the pathogenic microorganisms in patients with microbial keratitis (MK) through a better understanding of the corneal and ocular surface microbiome in health and disease. This will be achieved through the following objectives: 1. Using NGS, analyse the corneal microbiome of the affected and unaffected eye of patients with and without MK and compare with simultaneous results from CDC and MTPCR. 2. Determine the microbiological spectrum of the cornea, ocular surface and contiguous structures, in patients with MK, healthy controls, contact lens wearers and eye drop users. Outcome measures: 1. A comparison of isolation rates and identified bacteria obtained from CDC, MTPCR and NGS processing of MK corneal samples will be made. 2. Microorganisms identified in the eyes with MK will be compared to the fellow eye and other control groups and subtractive bioinformatics methodology applied to identify the most likely pathogenic organisms compared to those seen in the healthy corneal and ocular surface microbiome. 3. Comparisons of the relative abundance of microorganisms obtained from MK corneal samples over the participant's follow-up visits will be used to evaluate longitudinal changes in the corneal and ocular surface microbiome during treatment and resolution of MK. 4. A direct comparison between the relative abundance of microorganisms isolated from participants cornea, conjunctiva, eyelids and nose (contiguous structures) will be made to identify any possible endogenous sources of infection for MK. Population Eligibility: - All patients aged 18 years and over presenting with unilateral clinically suspected MK to St. Paul's Eye Unit, The Royal Liverpool University Hospital. - Patients with keratoconus undergoing cross-linking, subjects with no history of MK, subjects with no history of MK who are contact lens wearers and subjects with no history of MK but who are on eye drop treatment for glaucoma. Duration: Three years.

NCT ID: NCT02819232 Completed - Clinical trials for Infectious Keratitis

Microbiological Diagnosis of Infectious Keratitis to Pathogenic Fastidious Germs

Keratite
Start date: August 12, 2013
Phase: N/A
Study type: Interventional

Infectious keratitis are favored by the circumstances causing the small trauma of the corneal epithelium, corneal surgery, corneal dryness under health system such as Sjögren's syndrome rheumatoid arthritis, or much more frequently wearing contact lenses. If the majority of infectious keratitis are favourable, some lead to serious injury of the cornea, or even corneal perforation which result an endophthalmitis. This unfavourable evolution may lead to blindness due to corneal damage, the endo-ocular lesions or enucleation of the eyeball. This negative evolution is encountered while the infectious keratitis due to tedious germs of difficult diagnosis such as nontuberculous Mycobacterial, fungal infections, fungal keratitis, amoebic keratitis, and certain viral keratitis. The microbiological diagnosis of routine is based on the systematic search for pathogens tedious from invasive sampling of cornea by vaccinostyle. We set up a new non-invasive corneal swab diagnostic method.

NCT ID: NCT01831206 Completed - Bacterial Keratitis Clinical Trials

Collagen Cross-linking in Infectious Keratitis Trial

Start date: March 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy of collagen cross-linking for treatment of infectious keratitis.

NCT ID: NCT01739673 Completed - Clinical trials for Infectious Keratitis

Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis

Start date: August 2011
Phase: N/A
Study type: Interventional

This study is to evaluate the efficacy of ultraviolet-A (UVA) and riboflavin application (also often referred to as corneal collagen crosslinking) as a method to enhance treatment of infectious keratitis.